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Airway responsiveness to methacholine: effects of deep
inhalations and airway inflammation
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Brusasco, Vito, Emanuele Crimi, Giovanni Barisi-
one, Antonio Spanevello, Joseph R. Rodarte, and
Riccardo Pellegrino. Airway responsiveness to methacho-
line: effects of deep inhalations and airway inflammation. J.
Appl. Physiol. 87(2): 567–573, 1999.—We determined the
dose-response curves to inhaled methacholine (MCh) in 16
asthmatic and 8 healthy subjects with prohibition of deep
inhalations (DIs) and with 5 DIs taken after each MCh dose.
Flow was measured on partial expiratory flow-volume curves
at an absolute lung volume (plethysmographically deter-
mined) equal to 25% of control forced vital capacity (FVC).
Airway inflammation was assessed in asthmatic subjects by
analysis of induced sputum. Even when DIs were prohibited,
the dose of MCh causing a 50% decrease in forced partial flow
at 25% of control FVC (PD50MCh) was lower in asthmatic
than in healthy subjects (P , 0.0001). In healthy but not in
asthmatic subjects, repeated DIs significantly decreased the
maximum response to MCh [from 90 6 4 to 62 6 8 (SD) % of
control, P , 0.001], increased PD50MCh (P , 0.005), without
affecting the dose causing 50% of maximal response. In
asthmatic subjects, neither PD50MCh when DIs were prohib-
ited nor changes in PD50MCh induced by DIs were signifi-
cantly correlated with inflammatory cell numbers or percent-
ages in sputum. We conclude that 1) even when DIs are
prohibited, the responsiveness to MCh is greater in asthmatic
than in healthy subjects; 2) repeated DIs reduce airway
responsiveness in healthy but not in asthmatic subjects; and
3) neither airway hyperresponsiveness nor the inability of
DIs to relax constricted airways in asthmatic subjects is
related to the presence of inflammatory cells in the airways.
bronchial asthma; healthy; partial flow-volume curve; in-
duced sputum
AIRWAY HYPERRESPONSIVENESS has long been recognized
as a hallmark of bronchial asthma (24a, 25), but the
underlying mechanisms are still largely obscure. Al-
though a causal relationship between airway inflamma-
tion and airway hyperresponsiveness can be reason-
ably postulated, clear evidence for this hypothesis is
lacking (6). In 1981, Fish et al. (8) first submitted that
airway hyperresponsiveness may reflect inability to
dilate constricted airways rather than increased re-
sponse to stimuli. This hypothesis has recently received
support by Skloot et al. (31), who found similar metha-
choline (MCh) dose-response curves in asthmatic and
normal subjects when deep inhalations (DIs) were
strictly prohibited. A serious limitation of this study is
that the index of bronchoconstriction used, i.e., the time
constant of partial forced expiration, may be highly
sensitive to changes in lung volume (4). Burns and
Gibson (4) measured the instantaneous flow at con-
stant absolute lung volume on partial expiratory flow-
volume (PEFV) curves and found greater responses to
MCh in asthmatic than in normal subjects. A limitation
of this study is that a DI was required after each PEFV
curve to determine absolute lung volume. Neither
Skloot et al. (31) nor Burns and Gibson (4) examined
the possibility that the response to MCh in asthmatic
subjects was related to the degree of airway inflamma-
tion. Therefore, differences in subject characteristics
between the two studies cannot be excluded.
In the present study, we measured instantaneous
flow on PEFV curves in which absolute lung volume
was determined by body plethysmography, thus mak-
ing it possible to construct MCh dose-response curves
without DIs, independent of changes in lung volume.
The purposes of the study were the following: 1) to give
a definite answer on whether prohibition of DIs makes
the MCh dose-response curve in healthy subjects simi-
lar to that in asthmatic subjects, 2) to investigate to
what extent imposition of repeated DIs affects the MCh
dose-response curve in healthy and asthmatic subjects,
and 3) to investigate whether asthmatic airway inflam-
mation influences the MCh dose-response curve or the
effects of DIs on it.
METHODS
Subjects. Twenty-four subjects (8 who were healthy and 16
with mild asthma) participated in the study after giving
informed consent. The two groups were similar in terms of
age and baseline lung function, whereas the degree of airway
responsiveness to MCh, determined on a previous occasion by
a standard protocol (5), was greater in the asthmatic than in
the normal subjects (Table 1). None of the subjects was a
smoker or had suffered from viral infections of the upper
respiratory tract in the previous month before the study. The
asthmatic subjects were in stable condition and were taking
only short-acting b2-agonists on demand, which were avoided
for 12 h before the study. Subjects allergic to pollens were
studied out of season. All subjects, who were well trained in
performing respiratory maneuvers, attended the laboratory
on two occasions to undergo two different MCh challenges
(see below). The asthmatic subjects attended the laboratory
on a third occasion for sputum induction. In all subjects the
study was completed within 5 days.
The costs of publication of this article were defrayed in part by the
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Lung function measurements. A Vmax 6200 Autobox Sys-
tem (SensorMedics, Yorba Linda, CA) was used for all lung
function measurements. Thoracic gas volume (TGV) was
measured by whole-body plethysmography while the subject
panted slightly below 1 Hz against a closed shutter. Residual
volume (RV) was obtained by subtracting from TGV the
maximum volume that could be exhaled after the opening of
the shutter. Total lung capacity (TLC) was obtained by adding
inspiratory vital capacity to RV. Inspiratory and expiratory
flows were measured at the mouth by a mass flowmeter, and
volumes were obtained by digital integration of the flow
signals. Forced expiratory volume in 1 s (FEV1) and forced
vital capacity (FVC) were calculated from the best of three
acceptable forced expiratory maneuvers (1). Once reproduc-
ible (1) baseline lung function measurements had been ob-
tained, the study protocol was initiated and the subjects were
requested to refrain from sighing or taking DIs unless
specifically asked to do so.
Airway responses to MCh were determined by using par-
tial expiratory maneuvers, i.e., not preceded by a DI to TLC.
These were obtained by asking the subject to approximately
double his or her spontaneous tidal inspiration and then to
expire forcefully to RV. Flow was measured on PEFV curves
at an absolute lung volume corresponding to 25% of control
FVC (V˙p25), which was far from the peak flow of the PEFV
curve in all cases. This volume was determined at each step of
the challenge by measuring TGV immediately before the
partial expiratory maneuver.
MCh challenges. Solutions of MCh were prepared by
adding redistilled water to dry, powdered MCh chloride
(Laboratorio Farmaceutico Lofarma, Milan, Italy). Aerosols
were delivered during quiet tidal breathing by an SM-1
Rosenthal Breath-Activated Dosimeter (SensorMedics) driven
by compressed air (30 psi) with 1-s actuations. The aerosol
output at the mouth was 10 µl/actuation. Twenty inhalations
of saline were given as a control, and then MCh was given in
doubly increasing doses up to a maximum of 4.8 mg (noncumu-
lative), unless the subject asked for interruption at lower
doses. The dose increments were obtained by using two
concentrations of MCh (1 and 10 mg/ml) and increasing the
number of breaths from 2 to 48.
Two challenge procedures were used at random. In protocol
1, the subject continued to breathe quietly after MCh inhala-
tions until lung function measurements were started. In
protocol 2, the subject took five consecutive DIs from FRC to
TLC immediately after each MCh dose before entering the
plethysmograph for lung function measurements. In both
protocols, PEFV curves were obtained ,2 min after each
MCh dosing.
Dose-response curves. The changes in V˙p25 were plotted
against MCh doses. The maximal response of each individual
dose-response curve was determined by fourth-order polyno-
mial fitting. Bronchoconstriction was considered ‘‘unlimited’’
if no plateau of response was identified by inspection of the
fitted curve below a 90% decrease in V˙p25. The doses causing a
50% decrease in V˙p25 from control (PD50MCh) and 50% of
maximal response (ED50MCh) were calculated by linear
interpolation.
Sputum induction and analysis. After inhalation of al-
buterol (200 µg by metered dose inhaler), ultrasonically
nebulized (DeVilbiss 65, DeVilbiss, Somerset, PA) hypertonic
(4.5%) saline was inhaled for periods of 1, 2, 4, 8, and 16 min.
After each inhalation period the subject was asked to rinse
his or her mouth with water and cough to produce sputum.
Within 2 h from collection, the whole sputum sample was
examined by inverted microscopy, and portions were selected
to minimize salivary contamination. Dithiothreitol (Sputoly-
sin, Calbiochem, San Diego, CA) diluted (1:10) in distilled
water was added in a volume equal to twice the weight of the
selected sputum portion. After 20 min in a shaking water
bath (37°C), the sample was further diluted with PBS in a
volume equal to that of sputum plus dithiothreitol and PBS.
After mucus was removed by filtering through sterile gauze,
the suspension was centrifuged at 1,000 g for 5 min, and
supernatants were aspirated and stored (270°C). The cell
pellet was resuspended in a volume of PBS equal to that of the
filtered suspension, and total cells were counted by a Burker’s
chamber hemocytometer. The cell suspension was then centri-
fuged at 450 rpm for 6 min (Shandon 3 Cytocentrifuge,
Shandon Southern Instruments, Sewickley, PA). Differential
counts of 500 nucleated nonepithelial cells was made on two
cytospin slides fixed by methanol and stained by May Gru¨n-
wald Giemsa. Cytospins with .20% squamous epithelial cells
or ,50% cell viability were discarded.
Statistical analysis. Anthropometric and baseline lung
function data were analyzed by descriptive statistics and
unpaired Student’s t-test. The differences in maximal re-
sponse and PD50MCh between asthmatic and healthy sub-
jects with or without DIs were tested by a mixed (between-
within groups) repeated-measures ANOVA. PD50MCh and
ED50MCh values were log transformed before statistical
analysis and are presented as geometric means. Other data
are presented as means 6 SE. The relationships between
PD50MCh or its DI-induced changes and numbers (or percent-
Table 1. Demographics and functional characteristics
Subject
No. Gender
Age,
yr
Skin
Test
FEV1,
%Pred*
FVC,
%Pred*
PD20MCh,
µg
Healthy subjects
1 M 18 1 105 117 .1,200
2 M 39 2 105 106 .1,200
3 M 25 2 99 97 .1,200
4 M 40 2 96 107 .1,200
5 M 27 2 92 95 .1,200
6 M 35 2 81 82 .1,200
7 M 42 2 82 88 .1,200
8 M 34 2 81 86 .1,200
Mean 32 2 92 97 .1,200†
SE 3 4 4 1†
Asthmatic subjects
9 M 27 1 80 90 ,20
10 F 29 1 77 95 ,20
11 F 31 1 100 106 53
12 F 18 1 91 105 72
13 F 22 1 104 103 150
14 M 21 1 102 118 310
15 M 23 1 77 106 ,20
16 M 38 1 104 115 22
17 M 26 1 51 71 80
18 M 20 1 108 113 318
19 M 23 1 96 101 72
20 M 18 1 107 106 480
21 M 23 1 79 109 140
22 F 24 2 90 93 32
23 F 32 1 108 105 86
24 F 46 1 93 101 40
Mean 26 91 102 71†‡
SE 2 4 3 1.3†
FEV1, forced expiratory volume in 1 s; Pred, predicted; FVC, forced
vital capacity. *From Ref. 29; PD20MCh, dose of methacholine
causing a 20% decrease in FEV1 with a standard challenge protocol;
M, male; F, female; 1, positive; 2, negative. †Geometric. ‡Signifi-
cantly different from healthy subjects, P , 0.0001.
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ages) of inflammatory cells in sputum were evaluated by
simple correlation and stepwise multiple regression analysis.
RESULTS
Prohibition of DIs (protocol 1). The dose-response
curves to MCh in asthmatic and healthy subjects with
DIs prohibited are presented in Fig. 1. Maximal re-
sponse was not significantly different in the two groups
(99 6 1% in asthmatic vs. 90 6 4% in healthy subjects,
P . 0.6). Unlimited decrease in V˙p25 was observed in 6
healthy and 13 asthmatic subjects. PD50MCh (Fig. 2)
was significantly less in asthmatic than in healthy
subjects (geometric mean: 21 vs. 169 µg, P , 0.0001).
Effect of DIs (protocol 2 vs. protocol 1). In healthy
subjects, the dose-response curves to MCh for protocol 2
were displaced to the right compared with those for
protocol 1 (Fig. 1). Maximal response was significantly
less (P , 0.001) for protocol 2 (62 6 8% of control) than
for protocol 1 (90 6 4% of control). In all but one subject
there was a plateau in V˙p25 for protocol 2. PD50MCh
(Fig. 2) was significantly greater (P , 0.005) for proto-
col 2 (741 µg) than for protocol 1 (169 µg), but ED50MCh
values were not significantly different (222 vs. 154 µg,
P . 0.2). Baseline lung function on the two occasions
was not significantly different: FEV1 was 3.95 6 0.18
liters for protocol 1 and 4.01 6 0.20 liters for protocol 2
(P . 0.6).
In asthmatic subjects, the dose-response curves to
MCh for protocol 2 were not significantly different from
those for protocol 1 (Fig. 1). Neither maximal response
nor PD50MCh (Fig. 2) was significantly different be-
tween protocols (P . 0.9 for both comparisons). The
decrease in V˙p25 was unlimited in 12 of the 16 subjects.
Baseline lung function on the two occasions was not
significantly different: FEV1 was 3.34 6 0.18 liters for
protocol 1 and 3.48 6 0.20 liters for protocol 2 (P . 0.1).
Relationship to airway inflammation. Both total and
differential cell counts of induced sputum were greatly
variable in asthmatic subjects (Table 2). With DIs
prohibited (protocol 1), PD50MCh was also greatly
variable (from 5 to 118 µg) but did not correlate with
any inflammatory cell number or percentage in sputum
(Table 3). Also, a multiple regression model including
all inflammatory cell numbers in sputum as indepen-
dent variables was unable to explain a significant part
of the variability of PD50MCh with DIs prohibited (r2 5
0.29, P . 0.3). Also, changes in PD50MCh between
protocol 2 and protocol 1 did not correlate with any
inflammatory cell number or percentage in sputum by
using either simple (Table 3) or multivariate analysis
(r2 5 0.14, P . 0.7). The relationships between PD50MCh
or its DI-induced changes and the percentage of eosino-
phils in sputum (a widely used index of airway inflam-
mation in asthma) are shown in Fig. 3.
DISCUSSION
The main findings of this study are the following: 1)
even when DIs were prohibited, MCh dose-response
curves in asthmatic subjects were different from those
in healthy subjects; 2) multiple DIs during MCh chal-
lenge greatly reduced maximal bronchoconstriction and
increased PD50MCh in healthy, but not in asthmatic,
subjects, whereas ED50MCh was unchanged; and 3) in
asthmatic subjects, neither PD50MCh with DIs prohib-
ited nor changes in PD50MCh induced by DIs were
correlated with the numbers of inflammatory cells in
induced sputum.
Prohibition of DIs. Skloot et al. (31) recently reported
similar MCh dose-response curves in healthy and asth-
matic subjects when DIs were prohibited, but this
finding was not confirmed by Burns and Gibson (4). The
present study also showed different MCh dose-response
curves in asthmatic and healthy subjects even when
DIs were prohibited. Skloot et al. used the time con-
Fig. 1. Dose-response curves to MCh in asthmatic (n 5 16, dashed
lines) and healthy (n 5 8, solid lines) subjects without deep inhala-
tions (DIs) (protocol 1; no DIs) or with repeated DIs (protocol 2; DIs).
Values are means 6 SE. V˙p25, instantaneous flow from partial
flow-volume curve at 25% of control forced vital capacity. Note that
dose of MCh causing 50% of maximal response (ED50MCh) was
unchanged by DIs (arrows). Note also decrease in maximal response
in healthy (P , 0.001) but not in asthmatic subjects.
Fig. 2. Doses of MCh causing 50% decrease in V˙p25 (PD50MCh) in
asthmatic (A) and healthy (B) subjects with or without repeated DIs.
Note significant increase in PD50MCh in healthy but not in asthmatic
subjects. PD50MCh was significantly less in asthmatic than in
healthy subjects either with (P , 0.00001) or without (P , 0.0001)
DIs.
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stant of partial expiration as an index of bronchocon-
striction. This index is affected by changes in lung
volumes (4) and may underestimate bronchoconstric-
tion particularly in asthmatic subjects, in whom RV
increases more. In the extreme case of a parallel shift of
the descending limb of the flow-volume curve during
bronchoconstriction, due to an increase in RV without a
change in slope, the time constant of partial expiration
would not change despite a large decrement in expira-
tory flows (Fig. 4). Burns and Gibson used an index that
is independent of changes in lung volume, i.e., the
forced expiratory flow at constant lung volume on
PEFV curves, but a DI was required after completion of
each PEFV curve to estimate absolute lung volume.
They allowed 4 min between each DI and the next
PEFV curve, but this time interval may not be sufficient-
for the effect of DI to disappear completely (20). We
used the same index of bronchoconstriction as did
Burns and Gibson, but DIs were avoided by having
absolute lung volumes measured plethysmographically
before each PEFV curve.
In the study by Skloot et al. (31), partial forced
expiratory maneuvers were started from spontaneous
end-tidal volume, whereas in the present study they
were started from double the spontaneous end-tidal
volume. The somewhat greater stretching associated
with doubling tidal volume could have shifted the
dose-response curves of healthy but not of asthmatic
subjects to the right, thus contributing to the difference
between the two groups. This seems unlikely because,
in four additional healthy subjects, the dose-response
curves to MCh by using PEFV started from spontane-
ous end-tidal volume were not significantly different
Table 2. Differential cell counts in sputum of asthmatic subjects
Subject
No.
Total Cells,
3105/ml
Macrophages,
%
Lymphocytes,
%
Neutrophils,
%
Eosinophils,
%
Epithelial Cells,
%
9 16.0 45 0 2 53 0
10 33.6 88 1 6 5 0
11 60.8 72 0 6 22 0
12 32.0 53 5 40 1 1
13 8.0 92 0 0 8 0
14 36.0 53 3 35 7 2
15 64.0 80 2 8 10 0
16 20.8 89 2 8 1 0
17 48.0 60 5 28 7 0
18 64.0 83 1 12 4 0
19 11.2 91 0 2 6 1
20 80.0 56 0 39 5 0
21 48.0 25 1 74 0 0
22 16.0 36 1 3 60 0
23 18.4 31 2 19 48 0
24 9.6 78 17 2 3 0
Table 3. Simple correlation coefficients between airway
responsiveness and inflammatory cells
in induced sputum
Cells PD50 MCh PD50diff MCh
Macrophages
/ml 20.383 20.044
% 20.244 20.261
Lymphocytes
/ml 0.080 0.168
% 0.213 0.168
Neutrophils
/ml 0.407 0.465
% 0.294 0.121
Eosinophils
/ml 0.013 20.001
% 20.038 20.155
Values are Pearson’s correlation coefficients (n516). PD50 MCh,
dose of methacholine causing a 50% decrease in partial flow at 25% of
control forced vital capacity (V˙p25) with deep inhalations (DIs)
prohibited; PD50diffMCH, difference in PD50 MCh induced by repeated
DIs. None of these values was significant at P , 0.05.
Fig. 3. Relationships between sputum eosinophils and PD50MCh
with DIs prohibited (A) and DI-induced changes (PD50diffMCh; B).
Note that repeated DIs caused either increments (points above 0 line)
or decrements (points below 0 line) in PD50MCh irrespective of
percentage of eosinophils in sputum.
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from those started from double the spontaneous end-
tidal volume (PD50MCh geometric mean: 120 vs. 138 µg,
P . 0.6). The V˙p25 used in this study reflects events at
very low lung volume, whereas the time constant used
by Skloot et al. reflects the whole partial curve. In 7
healthy and 11 asthmatic subjects we could also con-
struct dose-response curves by using flow measured at
40% of FVC. The difference in the PD50MCh geometric
mean between asthmatic (179 µg) and healthy (24 µg)
subjects remained highly significant (P , 0.001), sug-
gesting that the absolute lung volume at which airway
caliber was assessed cannot explain the difference in
results between this and the study by Skloot et al.
Finally, it is possible that even small differences in
pattern of breathing during the whole challenge might
affect airway responsiveness.
Effect of DIs. During induced bronchoconstriction, a
single DI causes a transient increase in airway caliber
both in normal (24) and asthmatic (3) subjects, al-
though this effect is less in the latter (2, 3, 27, 28). This
bronchodilator effect, which can be explained by the
theory of relative hysteresis (11) without assuming
changes in airway smooth muscle tension, declines
with a time constant of 10–12 s (26). In protocol 2 of the
present study, changes in airway caliber were inferred
from PEFV curves obtained .45 s after the last DI to
TLC. Therefore, the different results obtained for proto-
col 1 and protocol 2 in healthy subjects cannot be
explained by the relative hysteresis theory. More likely,
the reduced responsiveness in protocol 2 reflects a
reduced force generation by airway smooth muscle.
Two theories have been proposed to explain why
stretching may reduce the force produced by airway
smooth muscle. According to Fredberg et al. (9) each
time inspiration occurs the airway smooth muscle is
elongated, because of the interdependence between
airways and lung parenchyma, and rapid-cycling cross
bridges are detached, thus decreasing the tensile force.
It is possible that increasing the magnitude of stretch-
ing by DIs immediately after each MCh dose in protocol
2 may have resulted in a greater rate of cross-bridge
detachment and, by inference, a decrease in tensile
force and less airway narrowing compared with proto-
col 1. According to Gunst et al. (13–15), the force
produced by airway smooth muscle depends on its
length when the stimulus is applied. If the airway
smooth muscle is stimulated when elongated, e.g.,
during DIs, and then brought to a shorter length, e.g.,
when normal tidal breathing is resumed, the force is
less than if airway smooth muscle is stimulated at
short length, e.g., during quiet tidal breathing. This
difference has been explained by different configura-
tions of the contractile apparatus inside the airway
smooth muscle (14). In the present study, MCh was
inhaled during quiet tidal breathing in both protocols
to avoid any effect of different breathing patterns on
aerosol deposition. After airway smooth muscle stretch-
ing, it takes time for the contractile apparatus to return
to the short-length configuration (30). In protocol 2,
airway smooth muscle was stretched for the first time
after control inhalation, thus possibly causing a configu-
rational change in the contractile apparatus that per-
sisted when MCh was inhaled. Therefore, both of the
above theories can explain the results of the present
study.
In healthy subjects, repeated DIs reduced maximal
response and increased PD50MCh without affecting
ED50MCh. The maximal response to bronchoconstrictor
stimuli in vivo is believed to be determined by the
force-generation capacity of airway smooth muscle, the
elastic loads opposing its shortening, and the thickness
of airway walls (23). Stretching of lung parenchyma in
healthy subjects may cause stress relaxation of its
elastic elements, which would favor and not oppose
Fig. 4. Changes in time constant (t) of partial expira-
tion (calculated as in Ref. 31), V˙p25, and residual
volume (RV) in 2 subjects [subject 13 (A) and subject
4 (B)]. Note parallel shift of flow-volume curve after
MCh (dashed line) due to large increase in RV in
subject 13 (asthmatic) and change in slope without
change in RV in subject 4 (healthy). Bronchoconstric-
tion is not detected by t in subject 13.
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airway narrowing. As airway wall thickness is unlikely
affected by DIs, the decrease in maximal response to
MCh in healthy subjects should reflect a decrease in
airway smooth muscle tensile force. ED50 is a measure
of the position of the dose-response curve that is
independent of maximal response. It reflects agonist-to-
receptor interaction (16) and should therefore not be
expected to change with DIs. PD50MCh is a threshold
dose and depends on both the position of the dose-
response curve and the maximal response. As ED50MCh
was not affected by DIs, the increase in PD50MCh in
this study appears totally determined by a reduction in
maximal response.
In asthmatic subjects, the dose-response curves to
MCh were unaffected by DIs. In most cases, an unlim-
ited decrease in V˙p25 was achieved with both protocols.
As complete airway closure may have occurred even
with submaximal airway smooth muscle activation,
ED50MCh could not be calculated, and the effects of DIs
on maximal response and position of the dose-response
curve cannot be separated. However, the similarity of
PD50MCh in protocol 1 and protocol 2 suggests that DIs
did not significantly affect the force-generation capacity
of the airway smooth muscle.
There are various reasons why DIs may not affect the
airway responsiveness to a constrictor agonist in
asthma. First, the force of interdependence in asthma
may be less than normal, because of a reduced lung
elastic recoil (10, 21), or is poorly transmitted to the
airway walls, because of peribronchial edema (18).
Second, asthmatic airway smooth muscle may generate
greater force because of hyperplasia or hypertrophy (7),
thus making the pulling effect of DI less efficient. Third,
parenchymal hysteresis may increase in response to
inhaled MCh in asthma (2), resulting in a reduced load
on airway smooth muscle during expiration from TLC.
If the velocity of airway smooth muscle shortening is
increased (22), then the contractile force may be fully
reestablished before the next inspiration, thus making
DIs ineffective in reducing airway smooth muscle force
(32).
Relationship to airway inflammation. Previous stud-
ies, using standard challenge procedures and FEV1 as
an index of bronchoconstriction, did not provide clear
evidence that airway hyperresponsiveness is related to
the presence of inflammatory cells in the airways (6).
The relationship between airway responsiveness and
airway inflammation with DIs prohibited has not been
investigated before. In the present study, no significant
correlations were found between PD50MCh without DIs
and inflammatory cell numbers in sputum, and the
relationships between changes in PD50MCh induced by
repeated DIs and inflammatory cells in sputum were
also insignificant. It appears, therefore, that breathing
maneuvers are not an important confounding factor in
the assessment of the relationships between airway
hyperresponsiveness and airway inflammation. On the
other hand, the evaluation of prohibition or imposition
of DIs on measurements of airway responsiveness does
not seem to be affected by the presence of inflammatory
cells in the airways. It is possible that changes affecting
the response to MCh and the ability to dilate the
airways with DIs reside deeper in the airway walls or at
the interface between airways and lung parenchyma.
Sputum analysis gives reproducible results (33) that
fairly well agree with those of bronchoalveolar lavage
(19) but only reveals inflammatory cells present in the
bronchial lumen. Therefore, the effects of chronic air-
way inflammation in terms of airway wall remodeling
cannot be evaluated.
Conclusions. This study confirms the conclusion by
Burns and Gibson (4) that airway hyperresponsiveness
is not just a problem of lack of dilatation with DI. In
addition, it also shows that prohibition of DIs during a
bronchial challenge greatly increases airway responsive-
ness in healthy subjects, thus making their MCh
dose-response curve more similar (although not equal)
to that of asthmatic subjects. These results have two
practical implications. First, the breathing pattern
during MCh challenge, both during aerosol inhalation
and during lung function measurements, may pro-
foundly affect measurements of airway responsiveness,
thus making comparable only measurements obtained
with the same protocol. Second, a protocol with re-
peated DIs allows a better separation between healthy
and asthmatic subjects.
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